Tim Watkins's most recent trade in Contineum Therapeutics Inc. - Ordinary Shares - Class A was a trade of 260,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Contineum Therapeutics Inc... | Tim Watkins | CMO & Head of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2025 | 260,000 | 260,000 | - | - | Stock Option (right to buy) | |
Contineum Therapeutics Inc... | Tim Watkins | CMO & Head of Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2025 | 26,000 | 26,000 | - | - | Stock Option (right to buy) |